1. Home
  2. MD vs VCEL Comparison

MD vs VCEL Comparison

Compare MD & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pediatrix Medical Group Inc.

MD

Pediatrix Medical Group Inc.

HOLD

Current Price

$21.81

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.53

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MD
VCEL
Founded
1979
1989
Country
United States
United States
Employees
4485
N/A
Industry
Hospital/Nursing Management
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
1995
1997

Fundamental Metrics

Financial Performance
Metric
MD
VCEL
Price
$21.81
$37.53
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$21.00
$57.50
AVG Volume (30 Days)
681.9K
586.8K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
1.91
0.25
Revenue
$1,922,442,000.00
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
$2.70
$18.55
P/E Ratio
$11.45
$151.65
Revenue Growth
N/A
14.05
52 Week Low
$11.84
$29.24
52 Week High
$24.99
$63.00

Technical Indicators

Market Signals
Indicator
MD
VCEL
Relative Strength Index (RSI) 47.69 48.73
Support Level $21.67 $35.99
Resistance Level $22.78 $41.65
Average True Range (ATR) 0.64 1.75
MACD 0.01 -0.01
Stochastic Oscillator 45.16 32.12

Price Performance

Historical Comparison
MD
VCEL

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: